An increase in IGF2 levels was found to cause disruption of pancreatic islets, whereas a decrease in IGF2 expression in human liver, muscles, and beta-cells reduced the risk of T2D [155]. The gene discussed is IGF2; the disease is type 2 diabetes mellitus.